Global COVID-19 RNA Vaccine Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The COVID-19 RNA Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global COVID-19 RNA Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
Global key companies of COVID-19 RNA Vaccine include MODERNA, CureVac, Zydus Cadila, BioNTech, and Stermirna, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
COVID-19 RNA Vaccine market is split by Type and by Application. For the period 2012-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe COVID-19 RNA Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of COVID-19 RNA Vaccine, with recent developments and future plans
Chapter 3, the COVID-19 RNA Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and COVID-19 RNA Vaccine market forecast, by regions, with revenue, from 2022 to 2028.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2022 to 2028.
Chapter 7 and 8, to describe COVID-19 RNA Vaccine research findings and conclusion, appendix and data source.
According to our latest research, the global COVID-19 RNA Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
Global key companies of COVID-19 RNA Vaccine include MODERNA, CureVac, Zydus Cadila, BioNTech, and Stermirna, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
COVID-19 RNA Vaccine market is split by Type and by Application. For the period 2012-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Being Developed
- Preclinical
- Clinical I
- Clinical II
- Pharmaceutical And Biotechnology Companies
- Hospital
- Academic And Research Organizations
- Other
- MODERNA
- CureVac
- Zydus Cadila
- BioNTech
- Stermirna
- North America
- Europe
- Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
- South America
- Middle East & Africa
Chapter 1, to describe COVID-19 RNA Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of COVID-19 RNA Vaccine, with recent developments and future plans
Chapter 3, the COVID-19 RNA Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and COVID-19 RNA Vaccine market forecast, by regions, with revenue, from 2022 to 2028.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2022 to 2028.
Chapter 7 and 8, to describe COVID-19 RNA Vaccine research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of COVID-19 RNA Vaccine
1.2 Classification of COVID-19 RNA Vaccine by Type
1.2.1 Overview: Global COVID-19 RNA Vaccine Market Size by Type: 2022 Versus 2028
1.2.2 Global COVID-19 RNA Vaccine Revenue Market Share by Type in 2028
1.2.3 Being Developed
1.2.4 Preclinical
1.2.5 Clinical I
1.2.6 Clinical II
1.3 Global COVID-19 RNA Vaccine Market by Application
1.3.1 Overview: Global COVID-19 RNA Vaccine Market Size by Application: 2022 Versus 2028
1.3.2 Pharmaceutical And Biotechnology Companies
1.3.3 Hospital
1.3.4 Academic And Research Organizations
1.3.5 Other
1.4 Global COVID-19 RNA Vaccine Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 COVID-19 RNA Vaccine Market Drivers
1.5.2 COVID-19 RNA Vaccine Market Restraints
1.5.3 COVID-19 RNA Vaccine Trends Analysis
2 COMPANY PROFILES
2.1 MODERNA
2.1.1 MODERNA Details
2.1.2 MODERNA Major Business
2.1.3 MODERNA COVID-19 RNA Vaccine Product and Solutions
2.1.4 MODERNA Recent Developments and Future Plans
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac COVID-19 RNA Vaccine Product and Solutions
2.2.4 CureVac Recent Developments and Future Plans
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila COVID-19 RNA Vaccine Product and Solutions
2.3.4 Zydus Cadila Recent Developments and Future Plans
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech COVID-19 RNA Vaccine Product and Solutions
2.4.4 BioNTech Recent Developments and Future Plans
2.5 Stermirna
2.5.1 Stermirna Details
2.5.2 Stermirna Major Business
2.5.3 Stermirna COVID-19 RNA Vaccine Product and Solutions
2.5.4 Stermirna Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global COVID-19 RNA Vaccine Revenue and Share by Players (2022 & 2028)
3.2 COVID-19 RNA Vaccine Players Head Office, Products and Services Provided
3.3 COVID-19 RNA Vaccine Mergers & Acquisitions
3.4 COVID-19 RNA Vaccine New Entrants and Expansion Plans
4 GLOBAL COVID-19 RNA VACCINE FORECAST BY REGION
4.1 Global COVID-19 RNA Vaccine Market Size by Region: 2022 VS 2028
4.2 Global COVID-19 RNA Vaccine Market Size by Region, (2022-2028)
4.3 North America
4.3.1 Key Companies of COVID-19 RNA Vaccine in North America
4.3.2 Current Situation and Forecast of COVID-19 RNA Vaccine in North America
4.3.3 North America COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
4.4 Europe
4.4.1 Key Companies of COVID-19 RNA Vaccine in Europe
4.4.2 Current Situation and Forecast of COVID-19 RNA Vaccine in Europe
4.4.3 Europe COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
4.5 Asia-Pacific
4.5.1 Key Companies of COVID-19 RNA Vaccine in Asia-Pacific
4.5.2 Current Situation and Forecast of COVID-19 RNA Vaccine in Asia-Pacific
4.5.3 Asia-Pacific COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
4.6 South America
4.6.1 Key Companies of COVID-19 RNA Vaccine in South America
4.6.2 Current Situation and Forecast of COVID-19 RNA Vaccine in South America
4.6.3 South America COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
4.7 Middle East & Africa
4.7.1 Key Companies of COVID-19 RNA Vaccine in Middle East & Africa
4.7.2 Current Situation and Forecast of COVID-19 RNA Vaccine in Middle East & Africa
4.7.3 Middle East & Africa COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
5 MARKET SIZE SEGMENT BY TYPE
5.1 Global COVID-19 RNA Vaccine Market Forecast by Type (2022-2028)
5.2 Global COVID-19 RNA Vaccine Market Share Forecast by Type (2022-2028)
6 MARKET SIZE SEGMENT BY APPLICATION
6.1 Global COVID-19 RNA Vaccine Market Forecast by Application (2022-2028)
6.2 Global COVID-19 RNA Vaccine Market Share Forecast by Application (2022-2028)
7 RESEARCH FINDINGS AND CONCLUSION
8 APPENDIX
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
1.1 Product Overview and Scope of COVID-19 RNA Vaccine
1.2 Classification of COVID-19 RNA Vaccine by Type
1.2.1 Overview: Global COVID-19 RNA Vaccine Market Size by Type: 2022 Versus 2028
1.2.2 Global COVID-19 RNA Vaccine Revenue Market Share by Type in 2028
1.2.3 Being Developed
1.2.4 Preclinical
1.2.5 Clinical I
1.2.6 Clinical II
1.3 Global COVID-19 RNA Vaccine Market by Application
1.3.1 Overview: Global COVID-19 RNA Vaccine Market Size by Application: 2022 Versus 2028
1.3.2 Pharmaceutical And Biotechnology Companies
1.3.3 Hospital
1.3.4 Academic And Research Organizations
1.3.5 Other
1.4 Global COVID-19 RNA Vaccine Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 COVID-19 RNA Vaccine Market Drivers
1.5.2 COVID-19 RNA Vaccine Market Restraints
1.5.3 COVID-19 RNA Vaccine Trends Analysis
2 COMPANY PROFILES
2.1 MODERNA
2.1.1 MODERNA Details
2.1.2 MODERNA Major Business
2.1.3 MODERNA COVID-19 RNA Vaccine Product and Solutions
2.1.4 MODERNA Recent Developments and Future Plans
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac COVID-19 RNA Vaccine Product and Solutions
2.2.4 CureVac Recent Developments and Future Plans
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila COVID-19 RNA Vaccine Product and Solutions
2.3.4 Zydus Cadila Recent Developments and Future Plans
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech COVID-19 RNA Vaccine Product and Solutions
2.4.4 BioNTech Recent Developments and Future Plans
2.5 Stermirna
2.5.1 Stermirna Details
2.5.2 Stermirna Major Business
2.5.3 Stermirna COVID-19 RNA Vaccine Product and Solutions
2.5.4 Stermirna Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global COVID-19 RNA Vaccine Revenue and Share by Players (2022 & 2028)
3.2 COVID-19 RNA Vaccine Players Head Office, Products and Services Provided
3.3 COVID-19 RNA Vaccine Mergers & Acquisitions
3.4 COVID-19 RNA Vaccine New Entrants and Expansion Plans
4 GLOBAL COVID-19 RNA VACCINE FORECAST BY REGION
4.1 Global COVID-19 RNA Vaccine Market Size by Region: 2022 VS 2028
4.2 Global COVID-19 RNA Vaccine Market Size by Region, (2022-2028)
4.3 North America
4.3.1 Key Companies of COVID-19 RNA Vaccine in North America
4.3.2 Current Situation and Forecast of COVID-19 RNA Vaccine in North America
4.3.3 North America COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
4.4 Europe
4.4.1 Key Companies of COVID-19 RNA Vaccine in Europe
4.4.2 Current Situation and Forecast of COVID-19 RNA Vaccine in Europe
4.4.3 Europe COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
4.5 Asia-Pacific
4.5.1 Key Companies of COVID-19 RNA Vaccine in Asia-Pacific
4.5.2 Current Situation and Forecast of COVID-19 RNA Vaccine in Asia-Pacific
4.5.3 Asia-Pacific COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
4.6 South America
4.6.1 Key Companies of COVID-19 RNA Vaccine in South America
4.6.2 Current Situation and Forecast of COVID-19 RNA Vaccine in South America
4.6.3 South America COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
4.7 Middle East & Africa
4.7.1 Key Companies of COVID-19 RNA Vaccine in Middle East & Africa
4.7.2 Current Situation and Forecast of COVID-19 RNA Vaccine in Middle East & Africa
4.7.3 Middle East & Africa COVID-19 RNA Vaccine Market Size and Prospect (2022-2028)
5 MARKET SIZE SEGMENT BY TYPE
5.1 Global COVID-19 RNA Vaccine Market Forecast by Type (2022-2028)
5.2 Global COVID-19 RNA Vaccine Market Share Forecast by Type (2022-2028)
6 MARKET SIZE SEGMENT BY APPLICATION
6.1 Global COVID-19 RNA Vaccine Market Forecast by Application (2022-2028)
6.2 Global COVID-19 RNA Vaccine Market Share Forecast by Application (2022-2028)
7 RESEARCH FINDINGS AND CONCLUSION
8 APPENDIX
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
LIST OF TABLES
Table 1. Global COVID-19 RNA Vaccine Revenue by Type, (USD Million), 2022 VS 2028
Table 2. Global COVID-19 RNA Vaccine Revenue by Application, (USD Million), 2022 VS 2028
Table 3. MODERNA Corporate Information, Head Office, and Major Competitors
Table 4. MODERNA Major Business
Table 5. MODERNA COVID-19 RNA Vaccine Product and Solutions
Table 6. CureVac Corporate Information, Head Office, and Major Competitors
Table 7. CureVac Major Business
Table 8. CureVac COVID-19 RNA Vaccine Product and Solutions
Table 9. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 10. Zydus Cadila Major Business
Table 11. Zydus Cadila COVID-19 RNA Vaccine Product and Solutions
Table 12. BioNTech Corporate Information, Head Office, and Major Competitors
Table 13. BioNTech Major Business
Table 14. BioNTech COVID-19 RNA Vaccine Product and Solutions
Table 15. Stermirna Corporate Information, Head Office, and Major Competitors
Table 16. Stermirna Major Business
Table 17. Stermirna COVID-19 RNA Vaccine Product and Solutions
Table 18. Global COVID-19 RNA Vaccine Revenue (USD Million) by Players (2022 & 2028)
Table 19. Global COVID-19 RNA Vaccine Revenue Share by Players (2022 & 2028)
Table 20. COVID-19 RNA Vaccine Players Head Office, Products and Services Provided
Table 21. COVID-19 RNA Vaccine Mergers & Acquisitions in the Past Five Years
Table 22. COVID-19 RNA Vaccine New Entrants and Expansion Plans
Table 23. Global Market COVID-19 RNA Vaccine Revenue (USD Million) Comparison by Region (2022 VS 2028)
Table 24. Global COVID-19 RNA Vaccine Revenue Market Share by Region (2022-2028)
Table 25. Key Companies of COVID-19 RNA Vaccine in North America
Table 26. Current Situation and Forecast of COVID-19 RNA Vaccine in North America
Table 27. Key Companies of COVID-19 RNA Vaccine in Europe
Table 28. Current Situation and Forecast of COVID-19 RNA Vaccine in Europe
Table 29. Key Companies of COVID-19 RNA Vaccine in Asia-Pacific
Table 30. Current Situation and Forecast of COVID-19 RNA Vaccine in Asia-Pacific
Table 31. Key Companies of COVID-19 RNA Vaccine in China
Table 32. Key Companies of COVID-19 RNA Vaccine in Japan
Table 33. Key Companies of COVID-19 RNA Vaccine in South Korea
Table 34. Key Companies of COVID-19 RNA Vaccine in South America
Table 35. Current Situation and Forecast of COVID-19 RNA Vaccine in South America
Table 36. Key Companies of COVID-19 RNA Vaccine in Middle East & Africa
Table 37. Current Situation and Forecast of COVID-19 RNA Vaccine in Middle East & Africa
Table 38. Global COVID-19 RNA Vaccine Revenue Forecast by Type (2022-2028)
Table 39. Global COVID-19 RNA Vaccine Revenue Forecast by Application (2022-2028)
Table 1. Global COVID-19 RNA Vaccine Revenue by Type, (USD Million), 2022 VS 2028
Table 2. Global COVID-19 RNA Vaccine Revenue by Application, (USD Million), 2022 VS 2028
Table 3. MODERNA Corporate Information, Head Office, and Major Competitors
Table 4. MODERNA Major Business
Table 5. MODERNA COVID-19 RNA Vaccine Product and Solutions
Table 6. CureVac Corporate Information, Head Office, and Major Competitors
Table 7. CureVac Major Business
Table 8. CureVac COVID-19 RNA Vaccine Product and Solutions
Table 9. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 10. Zydus Cadila Major Business
Table 11. Zydus Cadila COVID-19 RNA Vaccine Product and Solutions
Table 12. BioNTech Corporate Information, Head Office, and Major Competitors
Table 13. BioNTech Major Business
Table 14. BioNTech COVID-19 RNA Vaccine Product and Solutions
Table 15. Stermirna Corporate Information, Head Office, and Major Competitors
Table 16. Stermirna Major Business
Table 17. Stermirna COVID-19 RNA Vaccine Product and Solutions
Table 18. Global COVID-19 RNA Vaccine Revenue (USD Million) by Players (2022 & 2028)
Table 19. Global COVID-19 RNA Vaccine Revenue Share by Players (2022 & 2028)
Table 20. COVID-19 RNA Vaccine Players Head Office, Products and Services Provided
Table 21. COVID-19 RNA Vaccine Mergers & Acquisitions in the Past Five Years
Table 22. COVID-19 RNA Vaccine New Entrants and Expansion Plans
Table 23. Global Market COVID-19 RNA Vaccine Revenue (USD Million) Comparison by Region (2022 VS 2028)
Table 24. Global COVID-19 RNA Vaccine Revenue Market Share by Region (2022-2028)
Table 25. Key Companies of COVID-19 RNA Vaccine in North America
Table 26. Current Situation and Forecast of COVID-19 RNA Vaccine in North America
Table 27. Key Companies of COVID-19 RNA Vaccine in Europe
Table 28. Current Situation and Forecast of COVID-19 RNA Vaccine in Europe
Table 29. Key Companies of COVID-19 RNA Vaccine in Asia-Pacific
Table 30. Current Situation and Forecast of COVID-19 RNA Vaccine in Asia-Pacific
Table 31. Key Companies of COVID-19 RNA Vaccine in China
Table 32. Key Companies of COVID-19 RNA Vaccine in Japan
Table 33. Key Companies of COVID-19 RNA Vaccine in South Korea
Table 34. Key Companies of COVID-19 RNA Vaccine in South America
Table 35. Current Situation and Forecast of COVID-19 RNA Vaccine in South America
Table 36. Key Companies of COVID-19 RNA Vaccine in Middle East & Africa
Table 37. Current Situation and Forecast of COVID-19 RNA Vaccine in Middle East & Africa
Table 38. Global COVID-19 RNA Vaccine Revenue Forecast by Type (2022-2028)
Table 39. Global COVID-19 RNA Vaccine Revenue Forecast by Application (2022-2028)
LIST OF FIGURES
Figure 1. COVID-19 RNA Vaccine Picture
Figure 2. Global COVID-19 RNA Vaccine Revenue Market Share by Type in 2028
Figure 3. Being Developed
Figure 4. Preclinical
Figure 5. Clinical I
Figure 6. Clinical II
Figure 7. COVID-19 RNA Vaccine Revenue Market Share by Application in 2028
Figure 8. Pharmaceutical And Biotechnology Companies Picture
Figure 9. Hospital Picture
Figure 10. Academic And Research Organizations Picture
Figure 11. Other Picture
Figure 12. Global COVID-19 RNA Vaccine Market Size, (USD Million): 2022 VS 2028
Figure 13. Global COVID-19 RNA Vaccine Revenue and Forecast (2022-2028) & (USD Million)
Figure 14. COVID-19 RNA Vaccine Market Drivers
Figure 15. COVID-19 RNA Vaccine Market Restraints
Figure 16. COVID-19 RNA Vaccine Market Trends
Figure 17. MODERNA Recent Developments and Future Plans
Figure 18. CureVac Recent Developments and Future Plans
Figure 19. Zydus Cadila Recent Developments and Future Plans
Figure 20. BioNTech Recent Developments and Future Plans
Figure 21. Stermirna Recent Developments and Future Plans
Figure 22. Global COVID-19 RNA Vaccine Revenue Market Share by Region (2022-2028)
Figure 23. Global COVID-19 RNA Vaccine Revenue Market Share by Region in 2028
Figure 24. North America COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 25. Europe COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 26. Asia-Pacific COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 27. South America COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 28. Middle East & Africa COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 29. Global COVID-19 RNA Vaccine Market Share Forecast by Type (2022-2028)
Figure 30. Global COVID-19 RNA Vaccine Market Share Forecast by Application (2022-2028)
Figure 31. Methodology
Figure 32. Research Process and Data Source
Figure 1. COVID-19 RNA Vaccine Picture
Figure 2. Global COVID-19 RNA Vaccine Revenue Market Share by Type in 2028
Figure 3. Being Developed
Figure 4. Preclinical
Figure 5. Clinical I
Figure 6. Clinical II
Figure 7. COVID-19 RNA Vaccine Revenue Market Share by Application in 2028
Figure 8. Pharmaceutical And Biotechnology Companies Picture
Figure 9. Hospital Picture
Figure 10. Academic And Research Organizations Picture
Figure 11. Other Picture
Figure 12. Global COVID-19 RNA Vaccine Market Size, (USD Million): 2022 VS 2028
Figure 13. Global COVID-19 RNA Vaccine Revenue and Forecast (2022-2028) & (USD Million)
Figure 14. COVID-19 RNA Vaccine Market Drivers
Figure 15. COVID-19 RNA Vaccine Market Restraints
Figure 16. COVID-19 RNA Vaccine Market Trends
Figure 17. MODERNA Recent Developments and Future Plans
Figure 18. CureVac Recent Developments and Future Plans
Figure 19. Zydus Cadila Recent Developments and Future Plans
Figure 20. BioNTech Recent Developments and Future Plans
Figure 21. Stermirna Recent Developments and Future Plans
Figure 22. Global COVID-19 RNA Vaccine Revenue Market Share by Region (2022-2028)
Figure 23. Global COVID-19 RNA Vaccine Revenue Market Share by Region in 2028
Figure 24. North America COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 25. Europe COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 26. Asia-Pacific COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 27. South America COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 28. Middle East & Africa COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2022-2028)
Figure 29. Global COVID-19 RNA Vaccine Market Share Forecast by Type (2022-2028)
Figure 30. Global COVID-19 RNA Vaccine Market Share Forecast by Application (2022-2028)
Figure 31. Methodology
Figure 32. Research Process and Data Source
